These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Paroxysmal nocturnal hemoglobinuria: an historical overview. Parker CJ Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065 [TBL] [Abstract][Full Text] [Related]
5. [Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Pathogenic gene in paroxysmal nocturnal hemoglobinuria]. Kinoshita T Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2044-6. PubMed ID: 12187672 [No Abstract] [Full Text] [Related]
6. Paroxysmal nocturnal hemoglobinuria (PNH): an historical perspective. Benz EJ Hematology Am Soc Hematol Educ Program; 2008; ():92. PubMed ID: 19074064 [No Abstract] [Full Text] [Related]
7. Evolution of clinical understanding: paroxysmal nocturnal hemoglobinuria as a paradigm. Rosse WF Am J Hematol; 1993 Jan; 42(1):122-6. PubMed ID: 8416286 [TBL] [Abstract][Full Text] [Related]
10. Paroxysmal nocturnal haemoglobinuria: the current scenario. Pathare AV; Mohanty D J Postgrad Med; 1997; 43(1):26-8. PubMed ID: 10740713 [No Abstract] [Full Text] [Related]
11. [Progress in the field of hematology in the last 100 years: Medical history of paroxysmal nocturnal hemoglobinuria]. Kitani T Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2078-83. PubMed ID: 12187681 [No Abstract] [Full Text] [Related]
13. [Paul Strübing, the discoverer of paroxysmal nocturnal hemoglobinuria (Strübing-Marchiafava anemia)]. HEILMEYER L Dtsch Med Wochenschr; 1959 Feb; 84(8):335-6. PubMed ID: 13639657 [No Abstract] [Full Text] [Related]
14. Anaesthesia and orphan disease: laparoscopic cholecystectomy with paroxysmal nocturnal haemoglobinuria and human mAb therapy. Vargas M; Lallo C; Marra A; Servillo G Eur J Anaesthesiol; 2013 Dec; 30(12):770-2. PubMed ID: 23756354 [No Abstract] [Full Text] [Related]
15. Paroxysmal nocturnal hemoglobinuria first described in 1882 by Paul Strübing: an example of cooperation between clinical and basic research. Wilmanns JC Blut; 1982 Dec; 45(6):367-73. PubMed ID: 6753969 [TBL] [Abstract][Full Text] [Related]
16. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Bessler M; Mason P; Hillmen P; Luzzatto L Lancet; 1994 Apr; 343(8903):951-3. PubMed ID: 7909012 [TBL] [Abstract][Full Text] [Related]
17. Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients. Schmidt CQ; Harder MJ; Nichols EM; Hebecker M; Anliker M; Höchsmann B; Simmet T; Csincsi ÁI; Uzonyi B; Pappworth IY; Ricklin D; Lambris JD; Schrezenmeier H; Józsi M; Marchbank KJ Immunobiology; 2016 Apr; 221(4):503-11. PubMed ID: 26792457 [TBL] [Abstract][Full Text] [Related]
20. The acetylcholinesterase activity of the erythrocytes in paroxysmal nocturnal haemoglobinuria in relation to the severity of the disease. METZ J; BRADLOW BA; LEWIS SM; DACIE JV Br J Haematol; 1960 Oct; 6():372-80. PubMed ID: 13769901 [No Abstract] [Full Text] [Related] [Next] [New Search]